Anticoagulants in heart disease: current status and perspectives.

Anticoagulants in heart disease: current status and perspectives.

Bibliografske podrobnosti
Main Authors:	De Caterina, R, Husted, S, Wallentin, L, Agnelli, G, Bachmann, F, Baigent, C, Jespersen, J, Kristensen, S, Montalescot, G, Siegbahn, A, Verheugt, F, Weitz, J
Format:	Journal article
Jezik:	English
Izdano:	2007

Podobne knjige/članki

Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease.
od: De Caterina, R, et al.
Izdano: (2013)

Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
od: De Caterina, R, et al.
Izdano: (2013)

General mechanisms of coagulation and targets of anticoagulants (Section I). Position Paper of the ESC Working Group on Thrombosis--Task Force on Anticoagulants in Heart Disease.
od: De Caterina, R, et al.
Izdano: (2013)

New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
od: De Caterina, R, et al.
Izdano: (2012)

[Expert consensus document on the use of antiplatelet agents].
od: Patrono, C, et al.
Izdano: (2004)

Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology.
od: Patrono, C, et al.
Izdano: (2004)

Antiplatelet agents for the treatment and prevention of atherothrombosis.
od: Patrono, C, et al.
Izdano: (2011)

[Expert consensus document on the use of antiplatelet agents].
od: Patrono, C, et al.
Izdano: (2004)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
od: Roberto C. Montoya, et al.
Izdano: (2012-01-01)

Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention
od: Verheugt Freek WA, et al.
Izdano: (2001-05-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
od: Mohammadali Boroumand, et al.
Izdano: (2010-04-01)

Monitoring of Anticoagulant Therapy in Heart Disease: Considerations for the Current Assays
od: Hamidreza Goodarzynejad, et al.
Izdano: (2010-05-01)

New anticoagulants for the prevention of venous thromboembolism
od: Cecilia Becattini, et al.
Izdano: (2010-04-01)

Anticoagulation after Transcatheter Aortic Valve Implantation: Current Status
od: Antonio Greco, et al.
Izdano: (2020-04-01)

Epidemiological data on the use of traditional anticoagulants in cardiovascular disease
od: Reith, C, et al.
Izdano: (2018)

Investigation of the current status of anticoagulant resistance in UK Norway rats by VKORC1 genotyping
od: Clarke, D. J., et al.
Izdano: (2011-10-01)

Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis
od: Rocca, B, et al.
Izdano: (2018)

The Current Status of Direct Oral Anticoagulants in Cancer-Related Venous Thromboembolism Treatment
od: К. V. Lobastov, et al.
Izdano: (2020-05-01)

Current Anticoagulation Statuses among Older Chinese People with Nonvalvular Atrial Fibrillation
od: Junrong Jiang, et al.
Izdano: (2024-02-01)

Clinical effects of anticoagulants in suspected acute myocardial infarction - Reply
od: Collins, R, et al.
Izdano: (1997)

Genome-Wide Association Study Identifies That the ABO Blood Group System Influences Interleukin-10 Levels and the Risk of Clinical Events in Patients with Acute Coronary Syndrome.
od: Åsa Johansson, et al.
Izdano: (2015-01-01)

Oral anticoagulation – current knowlegde
od: Anna Karaś, et al.
Izdano: (2022-10-01)

Repeated Measurement of the Novel Atrial Biomarker BMP10 (Bone Morphogenetic Protein 10) Refines Risk Stratification in Anticoagulated Patients With Atrial Fibrillation: Insights From the ARISTOTLE Trial
od: Konstantinos I. Gkarmiris, et al.
Izdano: (2024-04-01)

Comorbidity Differentiation and Risk Stratification in the Elderly Patient with Polypharmacy: A Prospective Primary Care Registry on Oral Anticoagulation Therapy
od: S van Vugt, et al.
Izdano: (2020-05-01)

CURRENT VIEW ON ANTICOAGULANT AND THROMBOLYTIC TREATMENT OF ACUTE PULMONARY EMBOLISM
od: G. A. Ignatenko, et al.
Izdano: (2019-10-01)

Current status of heart transplantation in Turkey
od: Tahir Yağdı, et al.
Izdano: (2014-12-01)

Current status of heart failure in China
od: Xiaotong Cui, et al.
Izdano: (2017-01-01)

Current Controversies in Lupus Anticoagulant Detection
od: Gary W. Moore
Izdano: (2016-12-01)

Current practice and effects of intravenous anticoagulant therapy in hospitalized acute heart failure patients with sinus rhythm
od: Hiroki Nakano, et al.
Izdano: (2021-01-01)

Interaction of food supplement L-carnitine with oral anticoagulant acenocoumarol
od: HU Bachmann
Izdano: (2004-06-01)

Anticoagulation for Pregnant Patients with Mechanical Heart Valves
od: Srivastava AR, et al.
Izdano: (2007-01-01)

Postpartum anticoagulation in women with mechanical heart valves
od: Irani RA, et al.
Izdano: (2018-10-01)

Clinical and hemodynamic results of heart valve replacement; hemostasis correction with anticoagulants
od: G. V. Arkadieva, et al.
Izdano: (2005-06-01)

Genetic determinants of apixaban plasma levels and their relationship to bleeding and thromboembolic events
od: Sofia Attelind, et al.
Izdano: (2022-09-01)

The Current Status of Neuroprotection in Congenital Heart Disease
od: Kei Kobayashi, et al.
Izdano: (2021-12-01)

Current status of rheumatic heart disease in India
od: P.C. Negi, et al.
Izdano: (2019-01-01)

Antidote for new oral anticoagulants - present status
od: Abhijit S Nair, et al.
Izdano: (2017-01-01)

Left Ventricular Thrombosis: Current Perspective and Use of Direct Oral Anticoagulants
od: A. D. Aga, et al.
Izdano: (2023-01-01)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
od: Emmanuel J. Favaloro, et al.
Izdano: (2022-02-01)

THE ROLE OF ANTICOAGULATION THERAPY IN PATIENTS WITH PROSTHETIC HEART VALVES
od: N. A. Shostak, et al.
Izdano: (2016-09-01)